These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9779463)

  • 1. Generation of transporter-specific antibodies.
    Miller GW; Gilmor ML; Levey AI
    Methods Enzymol; 1998; 296():407-22. PubMed ID: 9779463
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular cloning of neurotransmitter transporter genes: beyond coding region of cDNA.
    Vandenbergh DJ
    Methods Enzymol; 1998; 296():498-514. PubMed ID: 9779470
    [No Abstract]   [Full Text] [Related]  

  • 3. Localization of transporters using transporter-specific antibodies.
    Danbolt NC; Lehre KP; Dehnes Y; Chaudhry FA; Levy LM
    Methods Enzymol; 1998; 296():388-407. PubMed ID: 9779462
    [No Abstract]   [Full Text] [Related]  

  • 4. Cloning and expression of a cocaine-sensitive rat dopamine transporter.
    Kilty JE; Lorang D; Amara SG
    Science; 1991 Oct; 254(5031):578-9. PubMed ID: 1948035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies to a brain dopamine binding protein: production, specificity, and immunohistochemistry.
    Hsu LL; Moroi K; Lakchaura BD; Chan T; Lin CT; Wu JY
    J Neurosci Res; 1987; 17(4):417-23. PubMed ID: 3305971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical analysis of dopamine transporter protein in Parkinson's disease.
    Miller GW; Staley JK; Heilman CJ; Perez JT; Mash DC; Rye DB; Levey AI
    Ann Neurol; 1997 Apr; 41(4):530-9. PubMed ID: 9124811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New dopaminergic neurons in Parkinson's disease striatum.
    Porritt MJ; Batchelor PE; Hughes AJ; Kalnins R; Donnan GA; Howells DW
    Lancet; 2000 Jul; 356(9223):44-5. PubMed ID: 10892768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of a dopamine transporter in PC12h cells: an immunohistochemical study with an antipeptide antibody.
    Kadota T; Yamaai T; Saitoh Y; Kawashima S; Moroi K; Kadota K
    Kaibogaku Zasshi; 1995 Jun; 70(3):248-51. PubMed ID: 7645373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo generation of chimeras.
    Buck KJ; Amara SG
    Methods Enzymol; 1998; 296():466-75. PubMed ID: 9779468
    [No Abstract]   [Full Text] [Related]  

  • 10. Localization of dopamine transporter protein by microscopic histochemistry.
    Kuhar MJ; Vaughan R; Uhl G; Cerruti C; Revay R; Freed C; Nirenburg M; Pickel V
    Adv Pharmacol; 1998; 42():168-70. PubMed ID: 9327870
    [No Abstract]   [Full Text] [Related]  

  • 11. Preparation of dopamine transporter-specific antibodies using molecular cloned genes.
    Lee SY; Im SY; Kim KM
    Arch Pharm Res; 1999 Jun; 22(3):262-6. PubMed ID: 10403128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning of genes or cDNAs encoding neurotransmitter transporters and their localization by immunocytochemistry.
    Nelson N; Liu QR
    Methods Enzymol; 1998; 296():52-64. PubMed ID: 9779439
    [No Abstract]   [Full Text] [Related]  

  • 13. Distribution and sites of synthesis of NTT4, an orphan member of the Na+/Cl(-)-dependent neurotransmitter transporter family, in the rat CNS.
    Luque JM; Jursky F; Nelson N; Richards JG
    Eur J Neurosci; 1996 Jan; 8(1):127-37. PubMed ID: 8713456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and functional characterization of a cocaine-sensitive dopamine transporter.
    Giros B; el Mestikawy S; Bertrand L; Caron MG
    FEBS Lett; 1991 Dec; 295(1-3):149-54. PubMed ID: 1765147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
    Tissingh G; Bergmans P; Winogrodzka A; Stoof JC; Wolters EC; Booij J; Van Royen EA
    J Nucl Med; 1997 Aug; 38(8):1271-2. PubMed ID: 9255164
    [No Abstract]   [Full Text] [Related]  

  • 16. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra.
    Hersch SM; Yi H; Heilman CJ; Edwards RH; Levey AI
    J Comp Neurol; 1997 Nov; 388(2):211-27. PubMed ID: 9368838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT transporter antibodies as a tool in serotonergic synaptosomal isolation.
    Lawrence JA; Charters AR; Butcher SP; Kelly JS; Olverman HJ
    Biochem Soc Trans; 1995 Feb; 23(1):115S. PubMed ID: 7758676
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopamine uptake by mouse neuroblastoma N1E-115 cells stably expressing human dopamine transporter is differentially inhibited by anti-idiotypic ab2beta antibodies mimicking the configuration of cocaine.
    Ho M; Segre M
    Brain Res; 2000 Jul; 872(1-2):231-5. PubMed ID: 10924700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural determinants of neurotransmitter transport using cross-species chimeras: studies on serotonin transporter.
    Barker EL; Blakely RD
    Methods Enzymol; 1998; 296():475-98. PubMed ID: 9779469
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring interactions of Bcl-2 family proteins in 96-well plate assays.
    Diaz JL; Oltersdorf T; Fritz LC
    Methods Enzymol; 2000; 322():255-66. PubMed ID: 10914023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.